Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

Last updated: May 19, 2025
Sponsor: CUTISS AG
Overall Status: Active - Not Recruiting

Phase

2

Condition

Hyponatremia

Skin Wounds

Treatment

EHSG-KF

STSG

Clinical Study ID

NCT03229564
TBRU-dS-BC-PIIb
  • Ages < 12
  • All Genders

Study Summary

This phase IIb trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in children with partial deep dermal and full thickness burns.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: <12 years of age

  • Deep partial thickness and/or full-thickness burns requiring surgical wound coverage

  • Expected that ≥90 cm2 of wound (not counting the head and neck area for studypatients in The Netherlands) will remain open at 4 weeks post burn despiteproceeding with treatment in accordance with the standard of care. >20% TBSA burnscan be taken as guideline, but TBSA is not an inclusion criterion.

  • Signed Informed consent

Exclusion

Exclusion Criteria:

  • Patients tested positive for HBV, HCV, syphilis or HIV

  • Patients with known underlying or concomitant medical conditions that may interferewith normal wound healing (e.g. systemic skin and connective tissue diseases, anykind of congenital defect of metabolism including insulin-dependent diabetesmellitus, Cushing syndrome or disease, scurvy, chronic hypothyroidism, congenital oracquired immunosuppressive condition, chronic renal failure, or chronic hepaticdysfunction (Child-Pugh class B or C), severe malnutrition, or other concomitantillness which, in the opinion of the Investigator, has the potential tosignificantly delay wound healing)

  • Severe drug and alcohol abuse

  • Patients with a known history of malignancy

  • Pre-existing coagulation disorders as defined by INR outside its normal value, PTT >ULN and fibrinogen <LLN prior to the current hospital admission and / or at theInvestigator's discretion

  • Patients with known allergies to amphotericin B, gentamicin, penicillin,streptomycin, or bovine collagen

  • Previous enrolment of the patient into the current phase II study

  • Participation of the patient in another study with conflicting endpoints within 30days preceding and during the present study

  • Patients or parents/legal guardian expected not to comply with the study protocol (including patients with severe cognitive dysfunction/impairment and severepsychiatric disorders)

  • Pregnant or breast feeding females

  • Suspicion of child abuse

  • Wounds in the head and neck area as study target area (only applicable for studypatients in The Netherlands)

  • Enrolment of the Investigator, his/her family members, employees and other dependentpersons

Study Design

Total Participants: 12
Treatment Group(s): 2
Primary Treatment: EHSG-KF
Phase: 2
Study Start date:
October 25, 2017
Estimated Completion Date:
June 30, 2028

Study Description

This multicentre phase IIb clinical trial will target patients from 1-17 years with severe burns to elucidate the benefit of a tissue-engineered autologous skin substitute for the patient group with the highest mortality rates. Particular emphasis, apart from safety, will be placed on efficacy, including the ratio of covered surface area to harvested surface area and scar quality, in comparison to meshed STSG.

Connect with a study center

  • Dipartimento di Chirurgia Pediatrica Ospedale dei bambini Vittorio Buzzi

    Milano,
    Italy

    Site Not Available

  • Unità di Chirurgia Plastica e Ustioni Ospedale Santobono

    Napoli,
    Italy

    Site Not Available

  • U.O.C. Grandi Ustionati Azienda Ospedale Università Padova

    Padova,
    Italy

    Site Not Available

  • Città della Salute

    Torino, 10126
    Italy

    Site Not Available

  • U.O. Chirurgia Plastica e Centro Ustioni Azienda Ospedaliera Universitaria Integrata Verona

    Verona,
    Italy

    Site Not Available

  • Rode Kruis Ziekenhuis

    Beverwijk, 1940
    Netherlands

    Site Not Available

  • University Children's Hospital Zurich

    Zurich, 8032
    Switzerland

    Site Not Available

  • University Hospitals Birmingham

    Birmingham, B15 2TH
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.